InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Montalbano, John. Director active across 2 companies, notably Eupraxia Pharmaceuticals Inc.. In total, 3 reports have been published. Breakdown: 1 buy · 0 sell. History available since 15 December 2025. The latest transaction was filed on 15 December 2025 (56 - Grant of rights). Regulator: SEDI. The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
John Montalbano is a declarant, with 3 filings in total. The 3 sampled filings run from 2025-12-19 to 2026-07-02, and the modal transaction nature is 46 - Compensation for services. He is listed as 4 - Director of Issuer at Manulife Financial Corporation and Eupraxia Pharmaceuticals Inc., both on XTSE. The buy and sell amounts shown for the sampled filings are 0 and 0 EUR.